Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Laboratory Corporation of America Holdings (NYSE:LH)

155.79
Delayed Data
As of 4:03pm ET
 -0.47 / -0.30%
Today’s Change
126.44
Today|||52-Week Range
164.22
+21.35%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Services to the Health Industry
MARKET CAP
$16.0B

Company Description

Laboratory Corp. of America Holdings operates as a clinical laboratory company, which engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the LabCorp Diagnostics and Covance Drug Development segments. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment involves in providing drug development solutions, to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.

Contact Information

Laboratory Corp. of America Holdings
358 South Main Street
Burlington North Carolina 27215-5837
P:(336) 229-1127
Investor Relations:

Employees

Shareholders

Other institutional49.17%
Mutual fund holders45.23%
Individual stakeholders1.14%

Top Executives

David P. KingChairman, President & Chief Executive Officer
Glenn A. EisenbergChief Financial Officer, Treasurer & Executive VP
Marcia T. EisenbergChief Scientific Officer & Senior Vice President
Mark Elliott BrecherChief Medical Officer & Senior Vice President
Lance V. BerberianChief Information Officer & Senior Vice President